<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">87529</article-id><article-id pub-id-type="doi">10.7554/eLife.87529</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.87529.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Therapeutic doses of ketamine acutely attenuate the aversive effect of losses during decision-making</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-310114"><name><surname>Oemisch</surname><given-names>Mariann</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69796"><name><surname>Seo</surname><given-names>Hyojung</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2928-9018</contrib-id><email>Hyojung.seo@yale.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Department of Neuroscience, Yale School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Department of Psychiatry and Neuroscience, Yale School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Izquierdo</surname><given-names>Alicia</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wong</surname><given-names>Ma-Li</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>05</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP87529</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-03-15"><day>15</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-01-31"><day>31</day><month>01</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.07.25.501468"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-06-23"><day>23</day><month>06</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87529.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-03-04"><day>04</day><month>03</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87529.2"/></event></pub-history><permissions><copyright-statement>© 2023, Oemisch and Seo</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Oemisch and Seo</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-87529-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-87529-figures-v1.pdf"/><abstract><p>The discovery of rapid-acting antidepressant, ketamine has opened a pathway to a new generation of treatments for depression, and inspired neuroscientific investigation based on a new perspective that non-adaptive changes in the intrinsic excitatory and inhibitory circuitry might underlie the pathophysiology of depression. Nevertheless, it still remains largely unknown how the hypothesized molecular and synaptic levels of changes in the circuitry might mediate behavioral and neuropsychological changes underlying depression, and how ketamine might restore adaptive behavior. Here, we used computational models to analyze behavioral changes induced by therapeutic doses of ketamine, while rhesus macaques were iteratively making decisions based on gains and losses of tokens. When administered intramuscularly or intranasally, ketamine reduced the aversiveness of undesirable outcomes such as losses of tokens without significantly affecting the evaluation of gains, behavioral perseveration, motivation, and other cognitive aspects of learning such as temporal credit assignment and time scales of choice and outcome memory. Ketamine’s potentially antidepressant effect was separable from other side effects such as fixation errors, which unlike outcome evaluation, was readily countered with strong motivation to avoid errors. We discuss how the acute effect of ketamine to reduce the initial impact of negative events could potentially mediate longer-term antidepressant effects through mitigating the cumulative effect of those events produced by slowly decaying memory, and how the disruption-resistant affective memory might pose challenges in treating depression. Our study also invites future investigations on ketamine’s antidepressant action over diverse mood states and with affective events exerting their impacts at diverse time scales.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>NMDA receptor</kwd><kwd>negative valence</kwd><kwd>reinforcement learning</kwd><kwd>affective memory</kwd><kwd>antidepressant</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rhesus macaque</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01 MH108643</award-id><principal-award-recipient><name><surname>Seo</surname><given-names>Hyojung</given-names></name><name><surname>Oemisch</surname><given-names>Mariann</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The NMDA receptor might preferentially mediate immediate experience/impact of events with negative over positive valence.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Depression is a debilitating mental illness that causes enormous personal sufferings as well as societal and economic burden (<xref ref-type="bibr" rid="bib49">Whiteford et al., 2013</xref>; <xref ref-type="bibr" rid="bib18">Greenberg et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Mrazek et al., 2014</xref>). The discovery of ketamine, a non-competitive <italic>N</italic>-methyl-<sc>D</sc>-aspartate (NMDA) receptor antagonist as a rapid-acting antidepressant, inspired extensive research to understand the mechanisms of ketamine’s action as well as a new perspective on the neurobiology of depression that depression might reflect non-adaptive changes in the glutamatergic and GABA (gamma aminobutyric acid)-ergic signal transmission of the prefrontal and limbic system in response to environmental stress and adversity (<xref ref-type="bibr" rid="bib5">Berman et al., 2000</xref>; <xref ref-type="bibr" rid="bib51">Zarate et al., 2006</xref>; <xref ref-type="bibr" rid="bib35">Sanacora et al., 2008</xref>; <xref ref-type="bibr" rid="bib27">Lapidus et al., 2014</xref>; <xref ref-type="bibr" rid="bib25">Krystal et al., 2013</xref>; <xref ref-type="bibr" rid="bib1">Abdallah et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Duman et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Murrough et al., 2017</xref>; <xref ref-type="bibr" rid="bib26">Krystal et al., 2019</xref>; <xref ref-type="bibr" rid="bib14">Duman et al., 2019</xref>). Despite recent progress in understanding the mechanisms of ketamine’s antidepressant action at cellular, synaptic, and network levels, many questions remain regarding enhancing the specificity to target depressive symptoms without undesirable side effects as well as long-term safety for repeated dosing (<xref ref-type="bibr" rid="bib23">Krystal et al., 1994</xref>; <xref ref-type="bibr" rid="bib36">Sanacora et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib7">Bonaventura et al., 2021</xref>).</p><p>A major gap in our knowledge that hampers the effort to design novel treatments with high specificity and low off-target effect lies at the functional-systems level to link cellular and synaptic phenomena to physiological and behavioral processes that directly cause the symptoms of depression. In light of symptomatic heterogeneity within the diagnostic category of mental disorders including depression, the importance of integrative and comprehensive analyses with regard to multiple functional domains/systems has been recognized to promote interpretable and translatable results from pre-clinical and clinical research (<xref ref-type="bibr" rid="bib12">Cuthbert, 2014</xref>; <xref ref-type="bibr" rid="bib22">Kozak and Cuthbert, 2016</xref>). Nevertheless, this type of analyses and results for assessing the behavioral effect of ketamine’s antidepressant action have seldom been available from the behavioral tests prevalently used in rodents (e.g. forced swim test, sucrose preference test, etc.) or self-reports from human subjects/patients. Another type of scarce data is early behavioral signs of ketamine’s action that might mediate and/or predict its longer-term effects. Ketamine has shown to induce rapid-onset (&lt;1 hr) cellular, molecular, physiological, and connectivity changes that are thought to reflect and/or mediate its antidepressant action (<xref ref-type="bibr" rid="bib29">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib50">Yang et al., 2018</xref>; <xref ref-type="bibr" rid="bib2">Al Shweiki et al., 2020</xref>; <xref ref-type="bibr" rid="bib19">Grimm et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Scheidegger et al., 2016</xref>; <xref ref-type="bibr" rid="bib17">Gould et al., 2019</xref>). In contrast, the acute behavioral effect that can be indicative of and/or predict longer-term effects has been hard to isolate from dissociative side effects.</p><p>Here, we assessed the effects of therapeutic doses of ketamine (0.5–1 mg/kg) administered intramuscularly (IM) or intranasally (IN) on cognitive, affective, and motivational aspects of learning and decision-making. Three rhesus monkeys performed a token-based biased matching pennies (BMP) game against a computerized opponent in which they gained or lost tokens as the outcome of their decisions (<xref ref-type="bibr" rid="bib39">Seo and Lee, 2009</xref>; <xref ref-type="bibr" rid="bib40">Seo et al., 2014</xref>). We found that ketamine acutely reduced the adverse effect of undesirable outcomes such as losses of tokens, which was independent of other side effects such as ocular nystagmus. However, ketamine did not significantly change animals’ motivation to earn reward, behavioral perseveration, or other cognitive aspects of learning and memory. These results constitute a rare report of an acute effect of therapeutic dose of ketamine on the processing of affectively negative events during dynamic decision-making. Our study also demonstrates the sensitivity and the potential of the non-human primate model in assessing behavioral and systems-level mechanisms of antidepressant action as well as investigating the pathophysiology of depression when combined with recently developed tools for large-scale neural recording and circuit manipulation.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Three rhesus monkeys were trained to play a token-based BMP game against a computerized opponent, in which their choice typically depended on the outcomes obtained from each choice in the past trials (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). In the control sessions where saline was administered, animals tended to repeat the choice that yielded a token, while switching away from the choice that led to non-gain outcomes, with a stronger tendency to switch after loss than neutral outcome (i.e. zero token) (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). The reinforcing and punishing effects of gain and non-gain outcomes also decayed exponentially over time, with the recent outcomes exerting a larger effect than remote ones. Ketamine selectively reduced the punishing effect of non-gain outcomes, with significantly larger change being induced after loss than neutral outcome (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). In addition, the ketamine-induced modulation was larger for the effect of recent than remote outcomes (analysis of variance [ANOVA], three-way interaction among outcome, trial lag, and drug condition, <italic>F</italic>(8, 1964) = 4.05, <italic>F</italic>(8, 1649) = 4.46, and <italic>F</italic>(8, 509) = 3.62 for animal P, Y, and B, respectively. p &lt; 0.001 in all animals for IM administration of 0.5 mg/kg; <italic>F</italic>(8, 1229) = 4.89, p &lt; 0.001 in animal P; <italic>F</italic>(8, 389) = 1.89, p = 0.06 in Y; <italic>F</italic>(8, 1002) = 3.27, p = 0.001 in B for IN administration of 1 mg/kg). 0.25 mg/kg of IM-administered and 0.5 mg/kg of IN-administered ketamine produced qualitatively similar results (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We focused our main analyses on the data collected with 0.5 mg/kg IM- and 1 mg/kg IN-administered ketamine, which produced comparable plasma concentration and behavioral effects (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Plasma concentration and its time course over 60 min were also comparable to those measured after 0.5 mg/kg in human subjects (<xref ref-type="bibr" rid="bib52">Zarate et al., 2012</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Biased matching pennies (BMP) task and ketamine-induced behavioral modulation.</title><p>(<bold>A</bold>) Temporal sequence of trial events. Gray cross indicates the target that the animal was required to fixate during each epoch. Each trial began with the animal’s gaze on the fixation target displayed on the center of a computer monitor for 0.5 s. Solid red disks around the fixation target indicated the tokens owned by the animal, namely asset, with empty disks serving as placeholders for the tokens to be acquired for exchange with juice reward. After two green disks were displayed for 0.5 s at the diametrically opposed positions along the horizontal meridian, the fixation target was extinguished signaling the animal to indicate its choice by shifting gaze to one of the two green disks. After 0.5 s of fixation, a feedback ring appeared around the chosen target with its color indicating the choice outcome, followed by the corresponding change in tokens. Once the animal collected six tokens, they were automatically exchanged with six drops of apple juice. After juice reward, the animal began the subsequent trial with two to four free tokens. Tokens and placeholders stayed on the screen throughout the trial and inter-trial interval. (<bold>B</bold>) Payoff matrix of BMP. (<bold>C</bold>) Coefficients from logistic regression models applied separately to the data from saline (sal) and ketamine (ket) sessions with intramuscular (IM, filled symbols) and intranasal (IN, empty symbols) administration. Standard errors are shown as horizontal bars above/below each coefficient. Lines are exponential functions best fit to the coefficients from saline (solid) and ketamine (dotted) sessions, and those from IM (thick) and IN (thin) sessions. Bars at the top of each panel indicate that the difference between saline and ketamine sessions is statistically significant with the horizontal position and color of each bar coding trial lag and outcome (same color scheme as that of saline sessions), respectively (independent sample <italic>t</italic>-test, <italic>p</italic> &lt; 0.05; IM and IN sessions were combined). For IM sessions, N=52 (Sal) and 17 (Ket) for monkey P; N=49 (Sal) and 15 (Ket) for monkey Y; N=25 (Sal) and 9 (Ket) for monkey B. For IN sessions, N=23 (Sal) and 13 (Ket) for monkey P; N=16 (Sal) and 10 (Ket) for monkey Y; N=19 (Sal) and 8 (Ket) for monkey B.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Means and standard errors of regression coefficients, and best-fit parameters of exponential functions.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Behavioral effect of 0.25 mg/kg intramuscularly (IM) administered (top) and 0.5 mg/kg intranasally (IN) administered (bottom) ketamine.</title><p>Regression coefficients reflecting the effects of gain, neutral (zero token), and loss outcomes obtained in the past trials are plotted. Solid and dotted lines represent data from saline and ketamine sessions, respectively. Solid (empty) symbols indicate that the corresponding coefficients are (not) significantly different from zero (one-sample <italic>t</italic>-test, p &lt; 0.05). * indicates that the coefficients from ketamine and saline sessions are significantly different for corresponding trial lag of outcome (independent sample <italic>t</italic>-test, <italic>p</italic> &lt; 0.05). Standard error is shown as horizontal bars above/below each coefficient. For IM sessions, N=50 (Sal) and 14 (Ket) for monkey P; N=36 (Sal) and 10 (Ket) for monkey Y. For IN sessions, N=34 (Sal) and 12 (Ket) for monkey P; N=28 (Sal) and 12 (Ket) for monkey B.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Means and standard errors of regression coefficients.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig1-figsupp1-v1.tif"/></fig></fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Time course of plasma concentration of ketamine following intramuscular (IM) and intranasal (IN) administration.</title><p>Dotted lines indicate the data from individual sessions, and dotted lines for average across individual sessions. Blood sample was taken every 20 min after injection.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data for plasma concentration used to generate the figure.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig2-v1.tif"/></fig><p>Outcome-dependent choice behavior and its modulation by ketamine were also parametrically modeled by exponential function, in which the initial impact of each outcome at the time of delivery gradually decayed over subsequent trials (<xref ref-type="disp-formula" rid="equ2">Equation 2</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Ketamine significantly reduced initial amplitude/impact of non-gain outcomes (<inline-formula><mml:math id="inf1"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula>) consistently in all three animals, and with both IM (<inline-formula><mml:math id="inf2"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.45 (P), 0.63 (Y), 1.36 (B) for loss, <italic>t</italic>-test, p &lt; <inline-formula><mml:math id="inf3"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>11</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> for all animals; <inline-formula><mml:math id="inf4"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.28 (P), 0.58 (Y), 0.61 (B) for neutral outcome, p &lt; <inline-formula><mml:math id="inf5"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> for all animals) and IN administration (<inline-formula><mml:math id="inf6"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.29 (P), 0.56 (Y), 1.36 (B) for loss, p &lt;  <inline-formula><mml:math id="inf7"><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>11</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> for all animals; <inline-formula><mml:math id="inf8"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 0.22 (P), 0.31 (Y), 0.83 (B) for neutral outcome, p &lt; 0.001 for all animals). Ketamine did not significantly modulate the time constant of decay, and the modulation of initial impact was sufficient to explain the behavioral phenomena.</p><p>Dependence of choice on the cumulative effect of temporally discounted past outcomes is the signature of reinforcement learning (RL) (<xref ref-type="bibr" rid="bib28">Lee et al., 2012</xref>). We used RL models to gain further insights into the possible mechanisms underlying ketamine-induced behavioral modulation (see Materials and methods). We first determined the variant/class of RL model that best explained the animals’ choice behavior under normal conditions (i.e. saline sessions) (<xref ref-type="table" rid="table1">Table 1</xref>). The differential forgetting (DF) model best fit the data in all three animals, in which the value functions of chosen and unchosen action decayed at different rates, with forgetting being slower for chosen than unchosen action (<xref ref-type="fig" rid="fig3">Figure 3</xref> and Table 3).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Reinforcement learning models for normal behavior during saline sessions.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Model</th><th align="left" valign="bottom"/><th align="left" valign="bottom">Value update</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="2"><bold>Q-learning (<italic>Q</italic></bold>)</td><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom"><inline-formula><mml:math id="inf9"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , if <italic>A</italic> is chosen.</td></tr><tr><td align="left" valign="bottom">Rt = 1, 0, −1 for gain, neutral, and loss, respectively.</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>Q-learning with subjective outcome evaluation</bold><break/>(<bold>QSE</bold>)</td><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom"><inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , if <italic>A</italic> is chosen.</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf13"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf14"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for gain, neutral, and loss (QSE).<break/><inline-formula><mml:math id="inf15"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0 (QSE-R)</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>Differential forgetting</bold><break/>(<bold>DF</bold>)</td><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom"><inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , if <italic>A</italic> is chosen.<break/><inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> , if <italic>A</italic> is not chosen.</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf19"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf20"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf21"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for gain, neutral, and loss (DF).<break/><inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0 (DF-R)</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>Non-differential forgetting (NDF</bold>)</td><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom"><inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , if <italic>A</italic> is chosen.<break/><inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> , if <italic>A</italic> is not chosen.</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for gain, neutral, and loss (NDF).<break/><inline-formula><mml:math id="inf29"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 0 (NDF-R)</td></tr><tr><td align="left" valign="bottom" rowspan="2"><bold>DF with asset-gated outcome evaluation</bold><break/>(<bold>DF-A</bold>)</td><td align="left" valign="bottom" rowspan="2"/><td align="left" valign="bottom"><inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi>λ</mml:mi><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , if <italic>A</italic> is chosen.<break/><inline-formula><mml:math id="inf31"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> , if <italic>A</italic> is not chosen.</td></tr><tr><td align="left" valign="bottom"><inline-formula><mml:math id="inf32"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = 1, 0, −1 for gain, neutral, and loss, respectively.</td></tr></tbody></table></table-wrap><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Model comparison for saline sessions.</title><p>Each row shows free (filled circles), unused (empty circles), and fixed (specific values) parameters of a variant of reinforcement learning (RL) model. For the details of RL models and parameters, see <xref ref-type="table" rid="table1">Table 1</xref>. Heat map on the right represents natural logarithm of differential BIC (Bayesian information criterion) of each variant from the best model. Best model for each animal is indicated by check (√) mark. <italic>Q(standard)</italic>: standard Q-learning model; <italic>Q-SE</italic>: Q-learning with subjective outcome evaluation; <italic>DF</italic>: differential forgetting model; <italic>DF-R</italic>: differential forgetting with neutral outcome being the reference point; <italic>NDF</italic>: non-differential forgetting model; <italic>NDF-R</italic>: non-differential forgetting model with neutral outcome being the reference point; <italic>NDF-A</italic>: non-differential forgetting model with asset-gated outcome evaluation.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical values of BIC used to generate the figure.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig3-v1.tif"/></fig><p>Building on the best model explaining normal behavior – the DF model, we asked how ketamine (0.5 mg/kg, IM) modulated the parameters of this model by testing variants of DF models, in each of which a different subset of parameters of the model were allowed to vary/deviate freely from the baseline parameters estimated from saline sessions (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Reinforcement learning models for ketamine-induced modulation of choice behavior.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"><italic>K</italic>-model</th><th align="left" valign="bottom">Hypothesis</th><th align="left" valign="bottom">Model parameters</th></tr></thead><tbody><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom" colspan="2"><bold>Value model</bold></td></tr><tr><td align="left" valign="bottom">1</td><td align="left" valign="bottom">Common modulation of LR/value for non-gain outcomes</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf33"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf34"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>k</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="inf35"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mi>k</mml:mi></mml:math></inline-formula>, for neutral and loss outcomes, respectively.</td></tr><tr><td align="left" valign="bottom">2</td><td align="left" valign="bottom">Differential modulation of LR/value for non-gain outcome</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf36"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf37"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf38"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , for neutral and loss outcomes, respectively.</td></tr><tr><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Differential modulation of LR/value for gain vs. non-gain outcome</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf40"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf41"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , <inline-formula><mml:math id="inf42"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> , for gain, neutral, and loss outcomes.</td></tr><tr><td align="left" valign="bottom">4</td><td align="left" valign="bottom">Differential modulation of LR/value for all the outcomes</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf43"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> = <inline-formula><mml:math id="inf44"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> <bold>,</bold> <inline-formula><mml:math id="inf45"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> <bold>,</bold> <inline-formula><mml:math id="inf46"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , for gain, neutral, and loss outcomes, respectively.</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom" colspan="2"><bold>Memory model</bold></td></tr><tr><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Differential modulation of forgetting rate for chosen and unchosen actions</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf47"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> <bold>,</bold> <inline-formula><mml:math id="inf48"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for chosen and unchosen action, respectively.</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom" colspan="2"><bold>Perseveration model</bold></td></tr><tr><td align="left" valign="bottom">6</td><td align="left" valign="bottom">Modulation of perseveration tendency</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf49"><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>ε</mml:mi></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi>ε</mml:mi><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula><break/><inline-formula><mml:math id="inf50"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 1 (−1), if right (left) target was chosen at trial <italic>t</italic>.</td></tr><tr><td align="left" valign="bottom">7</td><td align="left" valign="bottom">Modulation of LR/value and perseveration</td><td align="left" valign="bottom">Model 4 + model 6</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom" colspan="2"><bold>Temporal credit assignment (TCA) model</bold></td></tr><tr><td align="left" valign="bottom">8</td><td align="left" valign="bottom">Increase mis-assignment</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf51"><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><break/>+ <inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> + <inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>4</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><break/><inline-formula><mml:math id="inf54"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 1 (−1), if right (left) target was chosen at trial <italic>t</italic>.<break/><inline-formula><mml:math id="inf55"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = <inline-formula><mml:math id="inf56"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf57"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf58"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for gain, neutral, and loss t trial <italic>t</italic>.</td></tr><tr><td align="left" valign="bottom">9</td><td align="left" valign="bottom">Increase spread</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf59"><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><break/>+ <inline-formula><mml:math id="inf60"><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> + <inline-formula><mml:math id="inf61"><mml:msub><mml:mrow><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><break/><inline-formula><mml:math id="inf62"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = 1 (−1), if right (left) target was chosen at trial <italic>t</italic>.<break/><inline-formula><mml:math id="inf63"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = <inline-formula><mml:math id="inf64"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf65"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf66"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for gain, neutral, and loss at trial <italic>t</italic>.</td></tr><tr><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Increase statistical learning (SL)</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf67"><mml:msubsup><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi>ω</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula><break/><inline-formula><mml:math id="inf68"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo>⋅</mml:mo><mml:mi>I</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>&gt;</mml:mo><mml:mi>τ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mi>r</mml:mi><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mi>a</mml:mi><mml:mi>v</mml:mi><mml:mi>g</mml:mi><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula><break/><inline-formula><mml:math id="inf69"><mml:msub><mml:mrow><mml:mi>r</mml:mi><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula><break/>,<inline-formula><mml:math id="inf70"><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>ρ</mml:mi><mml:mi>*</mml:mi><mml:msub><mml:mrow><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula><break/><inline-formula><mml:math id="inf71"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>I</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mi>τ</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mrow><mml:mo>(</mml:mo><mml:mn>0</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>F</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:msub><mml:mi>q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>≥</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mo>&lt;</mml:mo><mml:mo>)</mml:mo></mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula><break/><inline-formula><mml:math id="inf72"><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>v</mml:mi><mml:mi>g</mml:mi><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>φ</mml:mi><mml:mi>*</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>v</mml:mi><mml:mi>g</mml:mi><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula><break/><inline-formula><mml:math id="inf73"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = <inline-formula><mml:math id="inf74"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf75"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf76"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for gain, neutral, and loss at trial <italic>t</italic>.</td></tr><tr><td align="left" valign="bottom"> </td><td align="left" valign="bottom" colspan="2"><bold>Motivation model</bold></td></tr><tr><td align="left" valign="bottom">11</td><td align="left" valign="bottom">Modulation of asset-gated outcome evaluation</td><td align="left" valign="bottom"><inline-formula><mml:math id="inf77"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:mi>λ</mml:mi><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , if <italic>A</italic> is chosen.<break/><inline-formula><mml:math id="inf78"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> , if <italic>A</italic> is not chosen.<break/><inline-formula><mml:math id="inf79"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> = <inline-formula><mml:math id="inf80"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf81"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf82"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> for gain, neutral, and loss at trial <italic>t</italic>.</td></tr></tbody></table></table-wrap><p>In all three animals, the model incorporating valence-dependent change in outcome evaluation best fit the choice data from ketamine sessions with (<italic>K</italic>-model 7 in the parenthesis, P) or without (<italic>K</italic>-model 4, P and Y/B) additional change in the tendency of choice perseveration (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="table" rid="table3">Table 3</xref>). Under ketamine, value update increased positively following all outcomes, thus increasing overall probability of repeating the same choice or namely, choice perseveration. However, the change was larger for non-gain outcomes, with the largest modulation after loss, consistent with the results from our model comparison that the model including only a perseveration component performed worse than the best model in all three animals (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Model comparison for the effects of ketamine.</title><p>Each row shows fixed (gray-filled circles), free (colored circles), and unused (empty circles) parameters of a variant of differential forgetting (DF) model. For the details of each model, see <xref ref-type="table" rid="table2">Table 2</xref>. <italic>θ</italic> represents a set of parameters added to a particular variant of DF model, and the number inside colored circles indicate the number of added parameters (&gt;1). For the details of each model, see <xref ref-type="table" rid="table2">Table 2</xref>. Heat map on the right represents natural logarithm of differential BIC (Bayesian information criterion) of each variant from the best model. Best model for each animal is indicated by check (√) mark. <italic>DF(saline)</italic>: differential forgetting model fit to the data from saline session; <italic>Common mod. non-gain</italic>: common modulation of non-gain outcome evaluation; <italic>Separate mod. neutral vs. loss</italic>: differential modulation of neutral and loss outcome evaluation; <italic>Separate mod. gain vs. non-gain</italic>: differential modulation of gain and non-gain outcome evaluation; <italic>Separate mod. all</italic>: outcome-dependent modulation of outcome evaluation; <italic>Separate mod. forgetting rate</italic>: differential modulation of forgetting rate for chosen and unchosen target; <italic>Inc perseveration</italic>: increased perseveration; <italic>Mod. value for all &amp; inc perseveration</italic>: outcome-dependent modulation of outcome evaluation and increased perseveration; <italic>Inc misassign</italic>: increased backward credit misassignment; <italic>Inc spread</italic>: increased forward spread in credit assignment; <italic>Inc statistical learning</italic>: increased statistical learning of reward rate; <italic>Mod. asset gating</italic>: modulation of asset-gated outcome evaluation.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical values of BIC used to generate the figure.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig4-v1.tif"/></fig><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Maximum likelihood parameter estimates of the best models for saline and ketamine sessions.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom"/><th align="left" valign="bottom"><inline-formula><mml:math id="inf83"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf84"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf85"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf86"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="inf87"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula></th></tr></thead><tbody><tr><td align="left" valign="bottom">P</td><td align="left" valign="bottom">Saline</td><td align="left" valign="bottom">0.72</td><td align="left" valign="bottom">0.09</td><td align="left" valign="bottom">−0.57</td><td align="left" valign="bottom">−1.3</td><td align="left" valign="bottom">−2.31</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Ketamine</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">0.40 (0.49)</td><td align="left" valign="bottom">0.11 (0.18)</td><td align="left" valign="bottom">−0.18 (−0.15)</td></tr><tr><td align="left" valign="bottom">Y</td><td align="left" valign="bottom">Saline</td><td align="left" valign="bottom">0.65</td><td align="left" valign="bottom">0.20</td><td align="left" valign="bottom">−0.54</td><td align="left" valign="bottom">−1.91</td><td align="left" valign="bottom">−3.15</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Ketamine</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">0.31</td><td align="left" valign="bottom">−0.18</td><td align="left" valign="bottom">−0.95</td></tr><tr><td align="left" valign="bottom">B</td><td align="left" valign="bottom">Saline</td><td align="left" valign="bottom">0.83</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">−1.07</td><td align="left" valign="bottom">−2.26</td><td align="left" valign="bottom">−4.12</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Ketamine</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td><td align="left" valign="bottom">0.18</td><td align="left" valign="bottom">−0.25</td><td align="left" valign="bottom">−1.01</td></tr></tbody></table></table-wrap><p>When the effect of ketamine was simulated with the best models within each class of ketamine models, <italic>K</italic>-model 4 (differential modulation of outcome evaluation for all three outcomes) produced the most similar results to actual data (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Ketamine-induced behavioral modulation simulated with differential forgetting model (for saline session) and best-fitting <italic>K</italic>-model (for ketamine session).</title><p>Simulated data were generated with the maximum likelihood parameters of best-fitting models for saline (differential forgetting model) and ketamine (<italic>K</italic>-model 4: differential modulation of value for all the outcomes) sessions. Simulated choice was analyzed with logistic regression model (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Means and standard errors of regerssion coefficients.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Ketamine-induced behavioral modulation simulated with best-fitting <italic>K-</italic>model of each class of reinforcement learning (RL) models.</title><p>Format is same as in <xref ref-type="fig" rid="fig4">Figure 4</xref>. Each column represents simulated data with best-fitting parameters for individual monkey (P, Y, and B from left to right).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Means and standard errors of regression coefficients.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Unlike monkeys Y and B, the best-fitting model for monkey P indicated that ketamine reduced overall tendency to switch choice in addition to outcome-dependent modulation of outcome evaluation. However, Bayesian information criterion (BIC) differed only slightly (dBIC = 3.99) between the best-fitting (<italic>K</italic>-model 7) and the second-best model (<italic>K</italic>-model 4) and the model predictions for choice behavior were very similar both qualitatively and quantitatively (<xref ref-type="table" rid="table3">Table 3</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>). We conclude that the behavioral effects of ketamine were consistent across all three monkeys. We did not find convincing evidence to support that ketamine significantly modulated cognitive (i.e. memory, temporal credit assignment [TCA] models) or motivational (i.e. motivation model) aspects of the animal’s behavior. However, ketamineinduced ocular nystagmus particularly when animals were holding fixation (i.e. pre-feedback fixation) on a peripheral target immediately after a choice was made.</p><p>Centripetal eye drift measured by eye velocity was significantly larger under ketamine (<xref ref-type="fig" rid="fig6">Figure 6</xref>; 0.5 mg/kg IM, three-way interaction among drug, dose, and time in ANOVA, <italic>F</italic>(3, 523) = 20.69, p &lt; 0.001 for P, <italic>F</italic>(3,439) = 118.33, p &lt; 0.001 for Y, two-way interaction between drug and time, <italic>F</italic>(3, 124) = 40.72, p &lt; 0.001 for B; 1 mg/kg IN, three-way interaction, <italic>F</italic>(3, 103) = 3.54, p = 0.018 for Y, <italic>F</italic>(3,242) = 6.26, p &lt; 0.001 for B, main effect of drug, <italic>F</italic>(1, 326) = 20.61, p &lt; 0.001 for P). Overall magnitude of nystagmus was significantly larger when ketamine was administered IM than IN (<italic>t</italic>-test, p &lt; 0.001 for all three animals).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Time course of ketamine-induced ocular nystagmus.</title><p>(<bold>A</bold>) Ocular position and velocity during fixation on the peripheral target in example trials during saline (left panel) and ketamine (right panel) sessions. (<bold>B</bold>) Time course of mean ocular velocity aligned at the time of saline or ketamine injection (monkey P, Y, and B from top to bottom). Shades indicate standard error. IM and IN indicates intramuscular and intranasal administration, respectively. For IM sessions, N=52 (Sal) and 17 (Ket) for monkey P; N=49 (Sal) and 15 (Ket) for monkey Y; N=25 (Sal) and 9 (Ket) for monkey B. For IN sessions, N=23 (Sal) and 13 (Ket) for monkey P; N=16 (Sal) and 10 (Ket) for monkey Y; N=19 (Sal) and 8 (Ket) for monkey B.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Means and standard errors of slow-phase ocular velocity (deg/s) used to generate <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig6-v1.tif"/></fig><p>Ketamine’s effects on both ocular nystagmus and negative evaluation of loss peaked and waned away within 1 hr after the injection (<xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig7">7</xref>). Despite the similar time course, further analysis suggested that these two effects were unlikely to be produced by a common mechanism/process. Nystagmus tended to cause fixation errors during the pre-feedback waiting period in a small number of trials. We found that as the animals owned more tokens and therefore were closer to earning juice reward, fixation errors became less frequent under ketamine (two-way interaction between drug condition and # of owned token in linear regression, <italic>t</italic> = −3.6, −3.3, and −9.5 for P, Y, and B, respectively, p &lt; 0.001 for all three animals; <xref ref-type="fig" rid="fig8">Figure 8A</xref>), suggesting that animals could counter the undesirable effect of ketamine when they had stronger motivation to obtain juice reward. However, ketamine-induced modulation of loss evaluation (i.e. reduced probability of choice switch after loss) did not systematically change with animals’ motivation gated by the number of accrued tokens (two-way interaction between drug condition and # of owned tokens in linear regression, p &gt; 0.25 for all three animals; <xref ref-type="fig" rid="fig8">Figure 8B</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Time course of ketamine-induced modulation of outcome-dependent choice behavior.</title><p>Time course of attenuation in loss evaluation induced by 0.5 mg/kg of intramuscularly (<bold>A</bold>) and 1 mg/kg of intranasally (<bold>B</bold>) administered ketamine. Regression coefficient reflecting ketamine’s modulation of the effect of each outcome from the previous trial (trial lag 1) is plotted as a function of time relative to the injection. Solid (empty) symbols indicate that coefficients are (not) significantly different from zero (t-test, p &lt; 0.05). Dotted lines represent standard error obtained from shuffled data (N=1000) between saline and ketamine sessions separately for each outcome. For IM sessions, N=52 (Sal) and 12 (Ket) for monkey P; N=49 (Sal) and 15 (Ket) for monkey Y; N=4 (Sal) and 7 (Ket) for monkey B.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Means and standard errors of differential regression coefficients.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig7-v1.tif"/></fig><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Effect of motivation on countering ketamine-induced fixation errors.</title><p>(<bold>A</bold>) Difference in the rate of fixation break/trial between ketamine and saline sessions is plotted as a function of cumulative number of tokens (as a proxy for time with the satiation effect being controlled). Number of tokens owned by the animal at a given trial (asset) is color coded. Vertical dotted lines demarcate the latest data point that was included in the linear regression analysis. (<bold>B</bold>) Difference in the probability of choice switch after loss from the previous trial (trial lag 1) between ketamine and saline sessions is plotted as a function of asset at the time of decision. Due to limited number of loss trials, analysis was performed after dividing trials into four groups according to asset (0–1, 2, 3, 4). N=52 (Sal) and 17 (Ket) for monkey P; N=49 (Sal) and 15 (Ket) for monkey Y; N=25 (Sal) and 9 (Ket) for monkey B.</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Differential error rate and probability of choice switch as the function of owned tokens.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig8-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig8-v1.tif"/></fig></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The acute behavioral effects of ketamine that might reflect antidepressant activity have seldom been systematically examined as the potential antidepressant effects could be obscured by dissociative side effects in the assessment based on self-report/rating (<xref ref-type="bibr" rid="bib5">Berman et al., 2000</xref>; <xref ref-type="bibr" rid="bib36">Sanacora et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Gould et al., 2019</xref>). Using a token-based decision task and extensive computational modeling, we examined the behavioral modulation induced by therapeutic doses of ketamine to gain insights into possible early signs of ketamine’s antidepressant activity. We identified the robust effect of ketamine in attenuating negative evaluation of decision outcomes, without affecting the animal’s motivation to obtain juice reward, the ability for proper TCA or the time constant of memory decay for decision outcomes.</p><p>Negative bias in perception, memory, feedback, and emotional processing has been reported to be one of the core behavioral/neuropsychological features of depression and negative affective bias, in particular, was proposed to play a causal role in the development, maintenance, and treatment of depression (<xref ref-type="bibr" rid="bib10">Clark et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">Roiser et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Godlewska and Harmer, 2021</xref>). Changes in emotional processing – increased (decreased) positive (negative) affective bias early in the course of antidepressant treatment were also reported to predict later clinical response (<xref ref-type="bibr" rid="bib47">Tranter et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Shiroma et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Browning et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Rychlik et al., 2017</xref>). While ketamine’s antidepressant effect is reported to be sustained over a week of period (<xref ref-type="bibr" rid="bib51">Zarate et al., 2006</xref>), ketamine’s effect on outcome evaluation was acute and did not last over subsequent days (<xref ref-type="fig" rid="fig9">Figure 9</xref>). This discrepancy might be attributable to the possible differences in the state of brain network between healthy subjects and those with depression as well as the type of measures taken to assess ketamine’s effect. It is noteworthy that even in our task in which the contingency of gains and losses were designed to reinforce dynamic choice, the impact of loss was cumulative as memory decayed slowly over trials and therefore, attenuation of initial impact of loss had a longer-term effect beyond the time of initial evaluation (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). In real-world situations where life events have consequences and their memory decays at much longer time scales than in our study, ketamine’s acute/early effect might be able to mediate longer-term changes in negative affective processing/schemata and mood while patients continue to interact with their social environment during the course of treatment (<xref ref-type="bibr" rid="bib16">Godlewska and Harmer, 2021</xref>; <xref ref-type="bibr" rid="bib41">Shiroma et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Soltani et al., 2021</xref>). Nevertheless, systematic studies are required to understand whether the reduced aversiveness to loss in our task might share the same mechanisms that underlie ketamine’s antidepressant action.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Behavioral effects of ketamine do not spread over the sessions subsequent to the injection.</title><p>Regression coefficients reflecting the effects of gain, neutral (zero token), and loss outcomes obtained in the past trials are plotted. Solid (dotted) lines represent data from saline sessions &gt;1 day (1 day) after a ketamine session. Solid (empty) symbols indicate that the corresponding coefficients are (not) significantly different from zero (<italic>t-</italic>test, <italic>p</italic> &lt; 0.05). Standard error is shown as horizontal bars above/below each coefficient. For IM sessions, N=37 (Sal) and 14 (Ket) for monkey P; N=35 (Sal) and 13 (Ket) for monkey Y; N=18 (Sal) and 6 (Ket) for monkey B. For IN sessions, N=37 (Sal) and 12 (Ket) for monkey P; N=25 (Sal) and 10 (Ket) for monkey Y.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Means and standard errors of regression coefficients.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87529-fig9-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-fig9-v1.tif"/></fig><p>Ketamine has been used as a pharmacological model of schizophrenia inducing cognitive deficits (<xref ref-type="bibr" rid="bib23">Krystal et al., 1994</xref>; <xref ref-type="bibr" rid="bib6">Blackman et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Fleming et al., 2022</xref>). Ketamine was reported to impair cognitive functions such as working memory, context-dependent behavioral control, task-switching, rule learning, and reasoning (<xref ref-type="bibr" rid="bib46">Taffe et al., 2002</xref>; <xref ref-type="bibr" rid="bib11">Condy et al., 2005</xref>; <xref ref-type="bibr" rid="bib43">Skoblenick and Everling, 2012</xref>; <xref ref-type="bibr" rid="bib24">Krystal et al., 2000</xref>; <xref ref-type="bibr" rid="bib9">Brunamonti et al., 2014</xref>). We tested multiple hypotheses regarding ketamine’s possible effects on the time constant of choice and outcome memory, accurate association between an outcome and its causative choice (i.e. TCA) and behavioral perseveration. Ketamine increased the overall probability of repeated choice. However, since this tendency was outcome dependent, with the effect being significantly larger for non-gain outcomes, and largest for loss, this effect cannot be entirely explained by increased perseveration alone. These results are consistent with a previous report that ketamine did not affect the process of learning, but only affected the integration of information for decision (<xref ref-type="bibr" rid="bib38">Scholl et al., 2014</xref>). These results also suggest that the memory of affective events and their associations (i.e. TCA) might be more resistant to acute disruption by NMDA receptor blockade, than affectively neutral information or rules. This disruption-resistant affective memory might underlie the delayed onset of antidepressant’s therapeutic effect and treatment-resistant depression.</p><p>It was reported that oculomotor side effects induced by ketamine rapidly decreased over repeated administrations (<xref ref-type="bibr" rid="bib32">Pouget et al., 2010</xref>). Interestingly, we found that ketamine-induced fixation errors could be countered at a very short time scale (i.e. on a trial basis) through animals’ strong motivation to earn juice reward, further corroborating our findings that ketamine did not change the animal’s motivation for reward.</p><p>Finally, our results demonstrate the sensitivity and the potential of the non-human primate model for investigation of the neurobiology of depression and antidepressant treatments, warranting further study on the mechanisms of ketamine’s antidepressant action over different mood states and contexts carrying affective events that have impacts at diverse time scales.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animal preparation</title><p>Three male monkeys (<italic>Macaca mulatta</italic>, P, Y, and B; body weight, 12–16 kg) were used. The animal was seated in a primate chair with its head fixed, and eye position was monitored with a high-speed eye tracker (ET 49, Thomas Recording, Giessen, Germany). All procedures used in this study were approved by the Institutional Animal Care and Use Committee at Yale University (Protocol #: 11058), and conformed to the Public Health Service <italic>Policy on Humane Care and Use of Laboratory Animals</italic> and <italic>Guide for the Care and Use of Laboratory Animals</italic>.</p></sec><sec id="s4-2"><title>Behavioral task</title><p>Animals were trained to perform a token-based BMP task (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Details of the task have been previously published (<xref ref-type="bibr" rid="bib39">Seo and Lee, 2009</xref>). Briefly, animals played a competitive BMP game against a computerized opponent and the outcome of each trial was determined jointly by the animal’s and the opponent’s choice according to the payoff matrix (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The payoff matrix was adjusted for each animal to produce comparable choice behavior across all three animals. When the animals matched the opponent’s choice, they gained one (monkey P) or two (monkey Y/B) tokens, whereas non-matching choices incurred either zero token (i.e. neutral outcome) or loss of one (Y/B) or two (P) tokens, with the probability of loss being higher (lower) than that of zero token for the risky (safe) target. The locations of ‘safe’ and ‘risky’ targets were fixed during a block of 40 trials and then switched with a probability of 0.1 afterwards. The computer opponent simulated a rational player who exploits any predictable patterns in the animal’s choice and outcome history to minimize the animal’s payoff (<xref ref-type="bibr" rid="bib39">Seo and Lee, 2009</xref>). To maximize payoff, the animals were required to dynamically change their choices to minimize serial correlations in the sequence of choice and outcome that could be exploited by the opponent.</p></sec><sec id="s4-3"><title>Administration of ketamine</title><p>For IM administration, 0.25 or 0.5 mg/kg of ketamine (Ketaset, Zoetis Inc) was injected into the right or left calf muscle. Doses were selected based on the therapeutic doses of ketamine when it is used as antidepressant for human patients. For IN administration, 0.5 or 1 mg/kg of ketamine was delivered into the right or left nostril using an IN mucosal atomization device (MAD Nasal, Teleflex Medical). Ketamine was administered with a 6.4-day interval on average (2–7 days), and sterile saline (IM) or sterile water (IN) were administered in-between successive ketamine sessions.</p></sec><sec id="s4-4"><title>Analysis of choice behavior</title><sec id="s4-4-1"><title>Logistic regression model</title><p>The effect of past outcomes on an animal’s choice was analyzed using the following model:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:munderover><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msubsup><mml:mi>G</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:munderover><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:munderover><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mi>L</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:munderover><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf88"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the probability of animal’s choosing right target at the current trial <italic>t</italic>, <italic>G</italic>(<italic>t</italic> − <italic>i</italic>), <italic>N</italic>(<italic>t − i</italic>), <italic>L</italic>(<italic>t − i</italic>), and <italic>R</italic>(<italic>t − i</italic>) are regressors encoding gain, neutral, loss, and juice reward outcome that occurred after right (left) choice in the <italic>i</italic>th trial into the past as 1 (<italic>−</italic>1), and other outcomes as 0, respectively. <inline-formula><mml:math id="inf89"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> are regression coefficients, with positive (negative) coefficients indicating that the particular outcome at trial t − <italic>i</italic> tended to increase (decrease) the animal’s tendency to choose the same target at trial <italic>t</italic>, relative to chance level (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Separate regression models were fit to saline, IM and IN administered ketamine sessions for each animal.</p></sec></sec><sec id="s4-5"><title>Nonlinear regression – exponential model</title><p>We modeled the temporal decay of the effect of past outcome over multiple trials and its modulation by ketamine with the following exponential function:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>Y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup><mml:mo>⋅</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>p</mml:mi><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>b</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup><mml:mo>⋅</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>o</mml:mi><mml:mo>=</mml:mo><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mo>,</mml:mo><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mo>∨</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <italic>i</italic> is trial lag (<italic>i</italic>th trial into the past), <inline-formula><mml:math id="inf90"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is an indicator variable encoding ketamine (saline) session as 1 (0). <inline-formula><mml:math id="inf91"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="inf92"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> are initial amplitude and decay time constant, respectively, for saline session, whereas <inline-formula><mml:math id="inf93"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="inf94"><mml:msubsup><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> are modulation by ketamine. Exponential functions were fit to the data with nonlinear regression using <italic>fitnlm.m</italic> in <italic>MATLAB</italic> (MathWorks), separately for each outcome.</p></sec><sec id="s4-6"><title>RL models</title><p>We used RL models to investigate the potential cognitive/computational processes that might be modulated by ketamine. RL models have been extensively and successfully applied to explain reward-guided choice behavior (<xref ref-type="bibr" rid="bib28">Lee et al., 2012</xref>). The general idea of RL is that the outcomes experienced from a particular action/state are integrated over time to form the reward expectation or the value of that action/state, and that an action among alternatives is chosen to maximize the expected outcome. One algorithm for the integration is to incrementally update the old expectation/value with a prediction error which can be formalized as follows for a single-state situation (<xref ref-type="bibr" rid="bib45">Sutton and Barto, 1998</xref>):<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>d</mml:mi><mml:mi>Q</mml:mi><mml:mo>−</mml:mo><mml:mi>l</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf95"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the value function for action <italic>A</italic> at trial <italic>t</italic>, <inline-formula><mml:math id="inf96"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is learning rate, and <inline-formula><mml:math id="inf97"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> is the discrepancy between actual outcome, <inline-formula><mml:math id="inf98"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and the expectation/value, namely reward prediction error. This formula can be rearranged as follows <xref ref-type="bibr" rid="bib4">Barraclough et al., 2004</xref>; <xref ref-type="bibr" rid="bib20">Ito and Doya, 2009</xref>:<disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf99"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf100"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are separate parameters for the forgetting rate of the old value estimate and the learning rate of a new outcome, respectively. With <inline-formula><mml:math id="inf101"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, the old value function decays exponentially over time, simulating forgetting. Action selection was modeled with a softmax function,<disp-formula id="equ5"> <label>(5)</label><mml:math id="m5"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mo>⋅</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>L</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where probability of choosing right target, <inline-formula><mml:math id="inf102"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>R</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> was a logistic function of the estimated value of right relative to left choice. Inverse temperature, <italic>β</italic> regulated randomness of choice determining the influence of action values on decision.</p><p>To investigate the effects of ketamine, we first tested multiple variants of the general model and determined the model that best explained normal behavior during saline sessions (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>). This is important, since we can expect to characterize the effect of ketamine accurately only in the context of a reliable behavioral model for how the animal’s behavior was influenced by the outcomes of their previous choices.</p><p>Then, we examined how the parameters of this model were modulated by ketamine (<xref ref-type="table" rid="table2">Table 2</xref>; <xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s4-7"><title>Model selection for saline sessions</title><p>In the most restricted, standard Q-learning model, value was updated only for the chosen action by taking a weighted average of <inline-formula><mml:math id="inf103"><mml:msub><mml:mrow><mml:mi>Q</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula> and <inline-formula><mml:math id="inf104"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> with <inline-formula><mml:math id="inf105"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> . <inline-formula><mml:math id="inf106"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> , was fixed as −1, 0, and 1 for gain, neutral, and loss outcome, respectively. These arrangements confined action value <italic>Q</italic> within the range of −1−1.</p><p>For three variants of RL models – Q-learning with subjective evaluation (QSE), DF, and non-differential forgetting (NDF) models, we relaxed the restrictions of the Q-learning model in two ways. <italic>First</italic>, <inline-formula><mml:math id="inf107"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was set as a free parameter reflecting subjective outcome evaluation. When both <inline-formula><mml:math id="inf108"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf109"><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are set as free parameters, the model becomes underdetermined. Therefore, in these models, the product of learning rate and outcome value, <inline-formula><mml:math id="inf110"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was consolidated into a single parameter <inline-formula><mml:math id="inf111"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> or the total amount of change due to a new outcome which could take different values for gain (<inline-formula><mml:math id="inf112"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), neutral (<inline-formula><mml:math id="inf113"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>), and loss (<inline-formula><mml:math id="inf114"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) outcome. We also tested the models in which <inline-formula><mml:math id="inf115"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was fixed as 0 simulating effectively neutral outcome. <italic>Second</italic>, action value <italic>Q</italic> for the unchosen action was allowed to decay, with DF rates for chosen (<inline-formula><mml:math id="inf116"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and unchosen (<inline-formula><mml:math id="inf117"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mo>-</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) actions in a DF model, and with a common forgetting rate, <inline-formula><mml:math id="inf118"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in an NDF model. Action values were updated only for the chosen action in a QSE model.</p><p>Finally, we tested an additional model in which outcome evaluation was gated by asset (non-DF with asset-gated outcome evaluation – NDF-A model) or the number of tokens owned by the animal at the time of decision, simulating temporal discounting of outcome value depending on its temporal distance to the primary reward that was always given only after six tokens were acquired.</p><p>For all tested models other than Q-learning model, <italic>β</italic> was fixed to be 1, as a model was underdetermined when both <italic>β</italic> and <inline-formula><mml:math id="inf119"><mml:msub><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> could vary freely. Model parameters were fit to choice data to maximize the likelihood of data. BIC was used for model comparison and selection of the best model.</p></sec><sec id="s4-8"><title>Model selection for ketamine sessions</title><p>To understand the effect of ketamine, we started with the best-fitting model of normal behavior during saline sessions – the DF model, and then asked how ketamine might modulate the parameters of this model. The null (baseline) model assumed that ketamine did not cause any parametric changes in the behavior, and the model prediction of trial-to-trial choice was generated with the maximum likelihood (ML) parameters, namely ‘baseline parameters’ estimated from saline sessions as follows:<disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>⋅</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mspace width="thinmathspace"/><mml:mi>A</mml:mi><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>⋅</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mspace width="thinmathspace"/><mml:mi>A</mml:mi><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ8"><mml:math id="m8"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mrow><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">g</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">v</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ9"><label>(8)</label><mml:math id="m9"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>R</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>L</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="inf120"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf121"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>F</mml:mi><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf122"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf123"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> , <inline-formula><mml:math id="inf124"><mml:msubsup><mml:mrow><mml:mo>∆</mml:mo></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> (baseline parameter-estimates) were ML parameters of the DF model fit to the data from saline sessions.</p><p>In each of the ketamine models, we set a subset of parameters of the DF model to freely vary from the baseline parameter-estimates. <italic>Value models</italic> (<italic>K</italic>-model 1–4, <xref ref-type="table" rid="table2">Table 2</xref>) hypothesized that ketamine changed outcome evaluation differentially for gain, neutral, and loss outcomes, whereas a <italic>memory model</italic> (<italic>K</italic>-model 5) tested whether ketamine affected the forgetting rate or the rate of value decay. <italic>Perseveration models</italic> hypothesized that ketamine affected the behavioral tendency to perseverate (<italic>K</italic>-model 6), possibly in tandem with a change in value update (<italic>K</italic>-model 7). <italic>TCA models</italic> tested whether ketamine changed the way a particular outcome properly updated the value of causative action, possibly leading to misassignment of the credit for an outcome to the choice that happened in the past (<italic>K</italic>-model 8), spread of the credit to future choice (<italic>K</italic>-model 9), or assignment of the credit for recent outcomes collectively to the frequently chosen target in the near past (<italic>K</italic>-model 10) (<xref ref-type="bibr" rid="bib48">Walton et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Jocham et al., 2016</xref>). Finally, a <italic>motivation model</italic> (<italic>K</italic>-model 11) hypothesized that ketamine changed the gain with which asset position modulated the value update for each outcome.</p></sec><sec id="s4-9"><title>Analysis of ketamine-induced ocular nystagmus</title><p>Ocular nystagmus during fixation on a peripheral target consists of two components – slow centripetal drift (i.e. slow phase), and a subsequent corrective saccade to re-capture the target (i.e. fast phase) (<xref ref-type="bibr" rid="bib3">Barnes, 1982</xref>). Eye position was sampled and recorded at 250 Hz. We used average velocity of eye movement during pre-feedback fixation on a chosen target to detect the slow phase of the nystagmus induced by ketamine. The sign of eye velocity was adjusted in the way that centripetal eye movement during fixation had negative velocity. Fast phase eye movement with velocity &gt;20° (visual angle)/s was first removed from the pre-feedback fixation period, and then eye velocity was averaged during the remaining time points of the fixation period for each trial (for statistical analysis) or in 1-min non-overlapping bins for visualization of time course (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p></sec><sec id="s4-10"><title>Analysis of plasma concentration of ketamine</title><p>To be able to effectively compare behavioral effects observed following IM and IN administration of ketamine, we measured plasma concentration of ketamine following IM and IN administrations in monkey B (one session for 0.5 mg/kg IM; two sessions for 0.5 mg/kg IN; two sessions for 1 mg/kg IN administration). Blood samples were collected at 10, 25, 40, 60, and 75 min following ketamine administration and analyzed with the high performance liquid chromatography (HPLC) protocol. 100 ng of the internal standard clonidine and 0.5 ml of thawed plasma were added to a 15-ml polypropylene tube and 15 ml of diethyl ether added. Following 5 min of vortex mixing, 4 ml of the upper ether layer was transferred to a new polypropylene tube and 250 µl of 0.01 M phosphoric acid added. After vortex mixing for 5 min, the lower aqueous layer was transferred to a 1.5-ml tube and evaporated under vacuum (~1 hr, SpeedVac evaporator, medium heat). The dry residue was dissolved in 150 μl of 0.01 sodium monobasic dihydrogen phosphate. 50 μl of the extract was injected and separated on a 3-μm Cyano Spherisorb HPLC column (4.6 × 100 mm) eluted with 80% 0.01 sodium acetate/20% acetonitrile (0.8 ml/min, 40°C). Norketamine, ketamine, and clonidine were detected by UV absorption (220 nm; Hitachi L-7400) with retention times of 6.1, 8.1, and 11.0 min, respectively; and with absolute detection limits of 0.2, 0.5, and 0.3 ng, respectively. Extracted standards were prepared using 0.5 ml aliquots of pooled human plasma. Plasma drug concentrations of samples were calculated knowing the peak height ratios of the extracted standards, the peak height ratios in samples and the amount of internal standard added (200 ng/ml). When injecting 50 μl of the extract, norketamine and ketamine were determined with concentration detection limits of 1 and 2 ng/ml, respectively.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Supervision, Investigation, Methodology, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All procedures used in this study were approved by the Institutional Animal Care and Use Committee at Yale University, and conformed to the Public Health Service Policy on Humane Care and Use of Laboratory Animals and Guide for the Care and Use of Laboratory Animals (Protocol #: 11058).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-87529-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Supporting files have been provided containing the numerical data used to generate the figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Melissa Boucher and Khalil AbedRabbo for their technical assistance. We also thank Drs. Daeyeol Lee and Amy Arnsten for their helpful discussion and thoughtful comments throughout the study. This work was supported by the National Institutes of Health (R01 MH108643).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdallah</surname><given-names>CG</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics</article-title><source>Annual Review of Medicine</source><volume>66</volume><fpage>509</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-053013-062946</pub-id><pub-id pub-id-type="pmid">25341010</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Shweiki</surname><given-names>MR</given-names></name><name><surname>Oeckl</surname><given-names>P</given-names></name><name><surname>Steinacker</surname><given-names>P</given-names></name><name><surname>Barschke</surname><given-names>P</given-names></name><name><surname>Pryce</surname><given-names>C</given-names></name><name><surname>Dorner-Ciossek</surname><given-names>C</given-names></name><name><surname>Schönfeldt-Lecuona</surname><given-names>C</given-names></name><name><surname>Hengerer</surname><given-names>B</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>S-ketamine induces acute changes in the proteome of the mouse amygdala</article-title><source>Journal of Proteomics</source><volume>216</volume><elocation-id>103679</elocation-id><pub-id pub-id-type="doi">10.1016/j.jprot.2020.103679</pub-id><pub-id pub-id-type="pmid">32032757</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>A procedure for the analysis of nystagmus and other eye movements</article-title><source>Aviation, Space, and Environmental Medicine</source><volume>53</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">7115257</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barraclough</surname><given-names>DJ</given-names></name><name><surname>Conroy</surname><given-names>ML</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Prefrontal cortex and decision making in a mixed-strategy game</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/nn1209</pub-id><pub-id pub-id-type="pmid">15004564</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>RM</given-names></name><name><surname>Cappiello</surname><given-names>A</given-names></name><name><surname>Anand</surname><given-names>A</given-names></name><name><surname>Oren</surname><given-names>DA</given-names></name><name><surname>Heninger</surname><given-names>GR</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Antidepressant effects of ketamine in depressed patients</article-title><source>Biological Psychiatry</source><volume>47</volume><fpage>351</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/s0006-3223(99)00230-9</pub-id><pub-id pub-id-type="pmid">10686270</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackman</surname><given-names>RK</given-names></name><name><surname>Macdonald</surname><given-names>AW</given-names></name><name><surname>Chafee</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Effects of ketamine on context-processing performance in monkeys: A new animal model of cognitive deficits in schizophrenia</article-title><source>Neuropsychopharmacology</source><volume>38</volume><fpage>2090</fpage><lpage>2100</lpage><pub-id pub-id-type="doi">10.1038/npp.2013.118</pub-id><pub-id pub-id-type="pmid">23660706</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaventura</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>S</given-names></name><name><surname>Carlton</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>MA</given-names></name><name><surname>Gomez</surname><given-names>JL</given-names></name><name><surname>Solís</surname><given-names>O</given-names></name><name><surname>Sánchez-Soto</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>PJ</given-names></name><name><surname>Fredriksson</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>CJ</given-names></name><name><surname>Sibley</surname><given-names>DR</given-names></name><name><surname>Shaham</surname><given-names>Y</given-names></name><name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name><name><surname>Michaelides</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability</article-title><source>Molecular Psychiatry</source><volume>26</volume><fpage>6704</fpage><lpage>6722</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01093-2</pub-id><pub-id pub-id-type="pmid">33859356</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>M</given-names></name><name><surname>Kingslake</surname><given-names>J</given-names></name><name><surname>Dourish</surname><given-names>CT</given-names></name><name><surname>Goodwin</surname><given-names>GM</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name><name><surname>Dawson</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Predicting treatment response to antidepressant medication using early changes in emotional processing</article-title><source>European Neuropsychopharmacology</source><volume>29</volume><fpage>66</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2018.11.1102</pub-id><pub-id pub-id-type="pmid">30473402</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunamonti</surname><given-names>E</given-names></name><name><surname>Mione</surname><given-names>V</given-names></name><name><surname>Di Bello</surname><given-names>F</given-names></name><name><surname>De Luna</surname><given-names>P</given-names></name><name><surname>Genovesio</surname><given-names>A</given-names></name><name><surname>Ferraina</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The NMDAr antagonist ketamine interferes with manipulation of information for transitive inference reasoning in non-human primates</article-title><source>Journal of Psychopharmacology</source><volume>28</volume><fpage>881</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1177/0269881114538543</pub-id><pub-id pub-id-type="pmid">24944084</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>L</given-names></name><name><surname>Chamberlain</surname><given-names>SR</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neurocognitive mechanisms in depression: implications for treatment</article-title><source>Annual Review of Neuroscience</source><volume>32</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.31.060407.125618</pub-id><pub-id pub-id-type="pmid">19400725</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condy</surname><given-names>C</given-names></name><name><surname>Wattiez</surname><given-names>N</given-names></name><name><surname>Rivaud-Péchoux</surname><given-names>S</given-names></name><name><surname>Gaymard</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Ketamine-induced distractibility: an oculomotor study in monkeys</article-title><source>Biological Psychiatry</source><volume>57</volume><fpage>366</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2004.10.036</pub-id><pub-id pub-id-type="pmid">15705352</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbert</surname><given-names>BN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology</article-title><source>World Psychiatry</source><volume>13</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1002/wps.20087</pub-id><pub-id pub-id-type="pmid">24497240</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Aghajanian</surname><given-names>GK</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants</article-title><source>Nature Medicine</source><volume>22</volume><fpage>238</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/nm.4050</pub-id><pub-id pub-id-type="pmid">26937618</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Altered connectivity in depression: gaba and glutamate neurotransmitter deficits and reversal by novel treatments</article-title><source>Neuron</source><volume>102</volume><fpage>75</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.03.013</pub-id><pub-id pub-id-type="pmid">30946828</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Jaynes</surname><given-names>FJB</given-names></name><name><surname>Thompson</surname><given-names>SL</given-names></name><name><surname>Corlett</surname><given-names>PR</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Targeted effects of ketamine on perceptual expectation during mediated learning in rats</article-title><source>Psychopharmacology</source><volume>239</volume><fpage>2395</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.1007/s00213-022-06128-2</pub-id><pub-id pub-id-type="pmid">35389087</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godlewska</surname><given-names>BR</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment</article-title><source>Psychopharmacology</source><volume>238</volume><fpage>1265</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1007/s00213-019-05448-0</pub-id><pub-id pub-id-type="pmid">31938879</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>TD</given-names></name><name><surname>Zarate</surname><given-names>CA</given-names></name><name><surname>Thompson</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Molecular pharmacology and neurobiology of rapid-acting antidepressants</article-title><source>Annual Review of Pharmacology and Toxicology</source><volume>59</volume><fpage>213</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1146/annurev-pharmtox-010617-052811</pub-id><pub-id pub-id-type="pmid">30296896</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>PE</given-names></name><name><surname>Fournier</surname><given-names>AA</given-names></name><name><surname>Sisitsky</surname><given-names>T</given-names></name><name><surname>Simes</surname><given-names>M</given-names></name><name><surname>Berman</surname><given-names>R</given-names></name><name><surname>Koenigsberg</surname><given-names>SH</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The economic burden of adults with major depressive disorder in the United States (2010 and 2018)</article-title><source>PharmacoEconomics</source><volume>39</volume><fpage>653</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1007/s40273-021-01019-4</pub-id><pub-id pub-id-type="pmid">33950419</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname><given-names>O</given-names></name><name><surname>Gass</surname><given-names>N</given-names></name><name><surname>Weber-Fahr</surname><given-names>W</given-names></name><name><surname>Sartorius</surname><given-names>A</given-names></name><name><surname>Schenker</surname><given-names>E</given-names></name><name><surname>Spedding</surname><given-names>M</given-names></name><name><surname>Risterucci</surname><given-names>C</given-names></name><name><surname>Schweiger</surname><given-names>JI</given-names></name><name><surname>Böhringer</surname><given-names>A</given-names></name><name><surname>Zang</surname><given-names>Z</given-names></name><name><surname>Tost</surname><given-names>H</given-names></name><name><surname>Schwarz</surname><given-names>AJ</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats</article-title><source>Psychopharmacology</source><volume>232</volume><fpage>4231</fpage><lpage>4241</lpage><pub-id pub-id-type="doi">10.1007/s00213-015-4022-y</pub-id><pub-id pub-id-type="pmid">26184011</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Doya</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Validation of decision-making models and analysis of decision variables in the rat basal ganglia</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>9861</fpage><lpage>9874</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6157-08.2009</pub-id><pub-id pub-id-type="pmid">19657038</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jocham</surname><given-names>G</given-names></name><name><surname>Brodersen</surname><given-names>KH</given-names></name><name><surname>Constantinescu</surname><given-names>AO</given-names></name><name><surname>Kahn</surname><given-names>MC</given-names></name><name><surname>Ianni</surname><given-names>AM</given-names></name><name><surname>Walton</surname><given-names>ME</given-names></name><name><surname>Rushworth</surname><given-names>MFS</given-names></name><name><surname>Behrens</surname><given-names>TEJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Reward-guided learning with and without causal attribution</article-title><source>Neuron</source><volume>90</volume><fpage>177</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.02.018</pub-id><pub-id pub-id-type="pmid">26971947</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozak</surname><given-names>MJ</given-names></name><name><surname>Cuthbert</surname><given-names>BN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The NIMH research domain criteria initiative: background, issues, and pragmatics</article-title><source>Psychophysiology</source><volume>53</volume><fpage>286</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1111/psyp.12518</pub-id><pub-id pub-id-type="pmid">26877115</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Karper</surname><given-names>LP</given-names></name><name><surname>Seibyl</surname><given-names>JP</given-names></name><name><surname>Freeman</surname><given-names>GK</given-names></name><name><surname>Delaney</surname><given-names>R</given-names></name><name><surname>Bremner</surname><given-names>JD</given-names></name><name><surname>Heninger</surname><given-names>GR</given-names></name><name><surname>Bowers</surname><given-names>MB</given-names><suffix>Jr</suffix></name><name><surname>Charney</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses</article-title><source>Archives of General Psychiatry</source><volume>51</volume><fpage>199</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.1994.03950030035004</pub-id><pub-id pub-id-type="pmid">8122957</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Bennett</surname><given-names>A</given-names></name><name><surname>Abi-Saab</surname><given-names>D</given-names></name><name><surname>Belger</surname><given-names>A</given-names></name><name><surname>Karper</surname><given-names>LP</given-names></name><name><surname>D’Souza</surname><given-names>DC</given-names></name><name><surname>Lipschitz</surname><given-names>D</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions</article-title><source>Biological Psychiatry</source><volume>47</volume><fpage>137</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/s0006-3223(99)00097-9</pub-id><pub-id pub-id-type="pmid">10664830</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond</article-title><source>Biological Psychiatry</source><volume>73</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2013.03.026</pub-id><pub-id pub-id-type="pmid">23726151</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Abdallah</surname><given-names>CG</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ketamine: a paradigm shift for depression research and treatment</article-title><source>Neuron</source><volume>101</volume><fpage>774</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.005</pub-id><pub-id pub-id-type="pmid">30844397</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapidus</surname><given-names>KAB</given-names></name><name><surname>Levitch</surname><given-names>CF</given-names></name><name><surname>Perez</surname><given-names>AM</given-names></name><name><surname>Brallier</surname><given-names>JW</given-names></name><name><surname>Parides</surname><given-names>MK</given-names></name><name><surname>Soleimani</surname><given-names>L</given-names></name><name><surname>Feder</surname><given-names>A</given-names></name><name><surname>Iosifescu</surname><given-names>DV</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Murrough</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A randomized controlled trial of intranasal ketamine in major depressive disorder</article-title><source>Biological Psychiatry</source><volume>76</volume><fpage>970</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2014.03.026</pub-id><pub-id pub-id-type="pmid">24821196</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Seo</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neural basis of reinforcement learning and decision making</article-title><source>Annual Review of Neuroscience</source><volume>35</volume><fpage>287</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-062111-150512</pub-id><pub-id pub-id-type="pmid">22462543</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>R-J</given-names></name><name><surname>Banasr</surname><given-names>M</given-names></name><name><surname>Dwyer</surname><given-names>JM</given-names></name><name><surname>Iwata</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X-Y</given-names></name><name><surname>Aghajanian</surname><given-names>G</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists</article-title><source>Science</source><volume>329</volume><fpage>959</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1126/science.1190287</pub-id><pub-id pub-id-type="pmid">20724638</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrazek</surname><given-names>DA</given-names></name><name><surname>Hornberger</surname><given-names>JC</given-names></name><name><surname>Altar</surname><given-names>CA</given-names></name><name><surname>Degtiar</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013</article-title><source>Psychiatric Services</source><volume>65</volume><fpage>977</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201300059</pub-id><pub-id pub-id-type="pmid">24789696</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murrough</surname><given-names>JW</given-names></name><name><surname>Abdallah</surname><given-names>CG</given-names></name><name><surname>Mathew</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Targeting glutamate signalling in depression: progress and prospects</article-title><source>Nature Reviews. Drug Discovery</source><volume>16</volume><fpage>472</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1038/nrd.2017.16</pub-id><pub-id pub-id-type="pmid">28303025</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouget</surname><given-names>P</given-names></name><name><surname>Wattiez</surname><given-names>N</given-names></name><name><surname>Rivaud-Péchoux</surname><given-names>S</given-names></name><name><surname>Gaymard</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys</article-title><source>Psychopharmacology</source><volume>209</volume><fpage>313</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-1797-8</pub-id><pub-id pub-id-type="pmid">20309530</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roiser</surname><given-names>JP</given-names></name><name><surname>Elliott</surname><given-names>R</given-names></name><name><surname>Sahakian</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cognitive mechanisms of treatment in depression</article-title><source>Neuropsychopharmacology</source><volume>37</volume><fpage>117</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/npp.2011.183</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rychlik</surname><given-names>M</given-names></name><name><surname>Bollen</surname><given-names>E</given-names></name><name><surname>Rygula</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ketamine decreases sensitivity of male rats to misleading negative feedback in a probabilistic reversal-learning task</article-title><source>Psychopharmacology</source><volume>234</volume><fpage>613</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1007/s00213-016-4497-1</pub-id><pub-id pub-id-type="pmid">27933365</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Zarate</surname><given-names>CA</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Manji</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders</article-title><source>Nature Reviews. Drug Discovery</source><volume>7</volume><fpage>426</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1038/nrd2462</pub-id><pub-id pub-id-type="pmid">18425072</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Frye</surname><given-names>MA</given-names></name><name><surname>McDonald</surname><given-names>W</given-names></name><name><surname>Mathew</surname><given-names>SJ</given-names></name><name><surname>Turner</surname><given-names>MS</given-names></name><name><surname>Schatzberg</surname><given-names>AF</given-names></name><name><surname>Summergrad</surname><given-names>P</given-names></name><name><surname>Nemeroff</surname><given-names>CB</given-names></name><collab>American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments</collab></person-group><year iso-8601-date="2017">2017</year><article-title>A consensus statement on the use of ketamine in the treatment of mood disorders</article-title><source>JAMA Psychiatry</source><volume>74</volume><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.0080</pub-id><pub-id pub-id-type="pmid">28249076</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheidegger</surname><given-names>M</given-names></name><name><surname>Henning</surname><given-names>A</given-names></name><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Kraehenmann</surname><given-names>R</given-names></name><name><surname>Boeker</surname><given-names>H</given-names></name><name><surname>Seifritz</surname><given-names>E</given-names></name><name><surname>Grimm</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation</article-title><source>Human Brain Mapping</source><volume>37</volume><fpage>1941</fpage><lpage>1952</lpage><pub-id pub-id-type="doi">10.1002/hbm.23148</pub-id><pub-id pub-id-type="pmid">26915535</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholl</surname><given-names>J</given-names></name><name><surname>Günthner</surname><given-names>J</given-names></name><name><surname>Kolling</surname><given-names>N</given-names></name><name><surname>Favaron</surname><given-names>E</given-names></name><name><surname>Rushworth</surname><given-names>MF</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name><name><surname>Reinecke</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A role beyond learning for NMDA receptors in reward-based decision-making—a pharmacological study using d-Cycloserine</article-title><source>Neuropsychopharmacology</source><volume>39</volume><fpage>2900</fpage><lpage>2909</lpage><pub-id pub-id-type="doi">10.1038/npp.2014.144</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Behavioral and neural changes after gains and losses of conditioned reinforcers</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>3627</fpage><lpage>3641</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4726-08.2009</pub-id><pub-id pub-id-type="pmid">19295166</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Donahue</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neural correlates of strategic reasoning during competitive games</article-title><source>Science</source><volume>346</volume><fpage>340</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1126/science.1256254</pub-id><pub-id pub-id-type="pmid">25236468</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiroma</surname><given-names>PR</given-names></name><name><surname>Thuras</surname><given-names>P</given-names></name><name><surname>Johns</surname><given-names>B</given-names></name><name><surname>Lim</surname><given-names>KO</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression</article-title><source>International Journal of Geriatric Psychiatry</source><volume>29</volume><fpage>1132</fpage><lpage>1139</lpage><pub-id pub-id-type="doi">10.1002/gps.4104</pub-id><pub-id pub-id-type="pmid">24706294</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>B</given-names></name><name><surname>Fong</surname><given-names>J</given-names></name><name><surname>Galvez</surname><given-names>V</given-names></name><name><surname>Shelker</surname><given-names>W</given-names></name><name><surname>Loo</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Side-effects associated with ketamine use in depression: a systematic review</article-title><source>The Lancet. Psychiatry</source><volume>5</volume><fpage>65</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(17)30272-9</pub-id><pub-id pub-id-type="pmid">28757132</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skoblenick</surname><given-names>K</given-names></name><name><surname>Everling</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>12018</fpage><lpage>12027</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1510-12.2012</pub-id><pub-id pub-id-type="pmid">22933786</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>JD</given-names></name><name><surname>Seo</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Timescales of cognition in the brain</article-title><source>Current Opinion in Behavioral Sciences</source><volume>41</volume><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.cobeha.2021.03.003</pub-id><pub-id pub-id-type="pmid">34026949</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>RS</given-names></name><name><surname>Barto</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="1998">1998</year><source>Reinforcement Learning: An Introduction</source><publisher-name>MIT Press</publisher-name></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taffe</surname><given-names>MA</given-names></name><name><surname>Davis</surname><given-names>SA</given-names></name><name><surname>Gutierrez</surname><given-names>T</given-names></name><name><surname>Gold</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Ketamine impairs multiple cognitive domains in rhesus monkeys</article-title><source>Drug and Alcohol Dependence</source><volume>68</volume><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/s0376-8716(02)00194-1</pub-id><pub-id pub-id-type="pmid">12234647</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tranter</surname><given-names>R</given-names></name><name><surname>Bell</surname><given-names>D</given-names></name><name><surname>Gutting</surname><given-names>P</given-names></name><name><surname>Harmer</surname><given-names>C</given-names></name><name><surname>Healy</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients</article-title><source>Journal of Affective Disorders</source><volume>118</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2009.01.028</pub-id><pub-id pub-id-type="pmid">19250683</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walton</surname><given-names>ME</given-names></name><name><surname>Behrens</surname><given-names>TEJ</given-names></name><name><surname>Buckley</surname><given-names>MJ</given-names></name><name><surname>Rudebeck</surname><given-names>PH</given-names></name><name><surname>Rushworth</surname><given-names>MFS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Separable learning systems in the macaque brain and the role of orbitofrontal cortex in contingent learning</article-title><source>Neuron</source><volume>65</volume><fpage>927</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.027</pub-id><pub-id pub-id-type="pmid">20346766</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteford</surname><given-names>HA</given-names></name><name><surname>Degenhardt</surname><given-names>L</given-names></name><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>Baxter</surname><given-names>AJ</given-names></name><name><surname>Ferrari</surname><given-names>AJ</given-names></name><name><surname>Erskine</surname><given-names>HE</given-names></name><name><surname>Charlson</surname><given-names>FJ</given-names></name><name><surname>Norman</surname><given-names>RE</given-names></name><name><surname>Flaxman</surname><given-names>AD</given-names></name><name><surname>Johns</surname><given-names>N</given-names></name><name><surname>Burstein</surname><given-names>R</given-names></name><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010</article-title><source>Lancet</source><volume>382</volume><fpage>1575</fpage><lpage>1586</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(13)61611-6</pub-id><pub-id pub-id-type="pmid">23993280</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Sang</surname><given-names>K</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ketamine blocks bursting in the lateral habenula to rapidly relieve depression</article-title><source>Nature</source><volume>554</volume><fpage>317</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nature25509</pub-id><pub-id pub-id-type="pmid">29446381</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name><name><surname>Singh</surname><given-names>JB</given-names></name><name><surname>Carlson</surname><given-names>PJ</given-names></name><name><surname>Brutsche</surname><given-names>NE</given-names></name><name><surname>Ameli</surname><given-names>R</given-names></name><name><surname>Luckenbaugh</surname><given-names>DA</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name><name><surname>Manji</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression</article-title><source>Archives of General Psychiatry</source><volume>63</volume><fpage>856</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.63.8.856</pub-id><pub-id pub-id-type="pmid">16894061</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name><name><surname>Brutsche</surname><given-names>N</given-names></name><name><surname>Laje</surname><given-names>G</given-names></name><name><surname>Luckenbaugh</surname><given-names>DA</given-names></name><name><surname>Venkata</surname><given-names>SLV</given-names></name><name><surname>Ramamoorthy</surname><given-names>A</given-names></name><name><surname>Moaddel</surname><given-names>R</given-names></name><name><surname>Wainer</surname><given-names>IW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression</article-title><source>Biological Psychiatry</source><volume>72</volume><fpage>331</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2012.03.004</pub-id><pub-id pub-id-type="pmid">22516044</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87529.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Izquierdo</surname><given-names>Alicia</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>The authors use reinforcement learning modeling to study the alterations following acute ketamine in macaques. The evidence supporting the conclusion that ketamine reduces the impact of losses vs. neutral/gains is <bold>solid</bold>. In this version of this <bold>valuable</bold> study, the authors make more measured interpretations about the relationship between the processing of losses and ketamine's antidepressant effects.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87529.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Oemisch and Seo use sophisticated reinforcement learning (RL) modeling to show that acute ketamine reduces the strength impact of losses vs neutral/gains on the subsequent trial performance of a token-based biased matching-pennies task. In this version, the authors make more measured interpretations about the potential relevance of their results to ketamine's antidepressant effects for the most part.</p><p>My prior review emphasized what I considered to be an over-interpretation of the relevance of their data (that I find interesting and of value) to mechanisms of action of ketamine's antidepressant effects. The authors have corrected those excesses exception for the last sentence of the introduction, which continues to suggest they are studying both mechanisms of antidepressant actions as well as the pathophysiology of depression.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87529.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Oemisch and Seo set out to examine the effects of low-dose ketamine on reinforcement learning, with the idea that alterations in reinforcement learning and/or motivation might inform our understanding of what alterations co-occur with potential antidepressant effects. Macaques performed a reinforced/punished matching pennies task while under effects of saline or ketamine administration and the data were fit to a series of reinforcement learning models to determine which model described behavior under saline most closely and then what parameters of this best-fitting model were altered by ketamine. They found a mixed effect, with two out of three macaques primarily exhibiting an effect of ketamine on the processing of losses and one out of three macaques exhibiting an effect of ketamine on processing losses and perseveration. They found that these effects of ketamine appeared to be dissociable from the nystagmus effects of the ketamine.</p><p>The findings are novel, and the data suggesting that ketamine primarily affects on the processing of losses (under the procedures used) are solid. However, it is unclear whether the connection between the processing of losses and the antidepressant effects of ketamine is justified, and the current findings may be more useful for those studying reinforcement learning than those studying depression and antidepressant effects. In addition, the co-occurrence of different behavioral procedures with different patterns of ketamine effects, with one macaque tested with different parameters than the other two exhibiting effects of ketamine that were best fit with a different model than the other two macaques, suggests that there may be difficulty in generalizing these findings to reinforcement learning more generally.</p><p>(1) First, the authors should be more explicit and careful in the connection they are trying to make about the link between loss processing and depression. The authors call their effect a &quot;robust antidepressant-like behavioral effect.&quot; However, there are no references to support this or discussion of how the altered loss processing would relate directly to the antidepressant effects. A few statements about a link to antidepressant effects have been removed or moderated, but many remain, including those in the abstract. The authors provide little to no support for this link, so the current version represents solid evidence for an effect on loss processing and incomplete or weak evidence for an antidepressant effect.</p><p>(2) It appears that the monkey P was given smaller rewards and punishers than the other two monkeys, and this monkey had an effect of ketamine on perseveration that was not observed in the other two monkeys. This may be due to this monkey being trained and tested before the other animals, but it does raise the issue of the generality of the authors' findings. It seems possible that the procedures used for the other two monkeys (with no deviation at all) might support the best-fit model that the authors favor. However, if changes in the size of the rewards and punishments suddenly make ketamine affect perseveration, then it suggests that ketamine's effect is highly parameter-specific. For example, might there be some parameters where ketamine would only alter perseveration and not loss processing?</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87529.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Seo</surname><given-names>Hyojung</given-names></name><role specific-use="author">Author</role><aff><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Oemisch</surname><given-names>Mariann</given-names></name><role specific-use="author">Author</role><aff><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>The modeling approaches are very sophisticated, and clearly demonstrate the selective nature of acute ketamine to reduce the impact of trial losses on subsequent performance, relative to neutral or gain outcomes. The authors then, not unreasonably, suggest that this effect is important in the context of the negative bias in interpreting events that is prominent in depression, in that if ketamine reduces the ability of negative outcomes to alter behavior, this may be a mechanism for its rapid acting antidepressant effects.</p><p>However, there is a very strong assumption in this regard, as shown by the first sentence of the discussion which implies this is a systematic study of ketamine's acute antidepressant effects. In actuality, this is a study of the acute effects of ketamine on reinforcement learning (RL) modeled parameters. A primary concern here is that an effect presented as a &quot;robust antidepressant-like behavioral effect&quot; should be more enduring than just an alteration during the acute administration. As it is, the link to an &quot;anti-depressant effect&quot; is based solely on the selective effects on losses. This is not to say this is not an interesting observation, worthy of exploration. It is noted that a similar lack of enduring effects on outcome evaluation is observed in humans, as shown in supplemental fig. S4, but there is not accompanying citation for the human work.</p></disp-quote><p>We agree with the reviewer that the way we linked the study results to ketamine’s antidepressant action can be misleading and based on a rather strong assumption which was not systematically tested in the study. We made the following changes to the manuscript:</p><p>(1) These results constitute a rare report of a robust antidepressant-like behavioral effect produced by therapeutic doses of ketamine during acute phase (&lt;1 hour) after injection (Introduction, 3rd paragraph, line 8-9 in the original manuscript).</p><p>Changed to: These results constitute a rare report of an acute effect of therapeutic dose of ketamine on the processing of affectively negative events during dynamic decision-making.</p><p>(2) We clarified in the Discussion that our study is to gain insights into, but not a systematic investigation of ketamine’s antidepressant action as follows:</p><p>(2.1) A sentence was added (1st paragraph of Discussion): Using a token-based decision task and extensive computational modeling, we examined the behavioral modulation induced by therapeutic doses of ketamine to gain insights into possible early signs of ketamine’s antidepressant activity.</p><p>(2.2) Consistent with the findings from humans, ketamine’s effect on outcome evaluation was acute and did not last over subsequent days (Supplemental Figure S4) (Discussion, 2nd paragraph, line 6-7 in the original manuscript).</p><p>Changed to: While ketamine’s antidepressant effect is reported to be sustained over a week of period (5), ketamine’s effect on outcome evaluation was acute and did not last over subsequent days (Supplemental Figure S4). This discrepancy might be attributable to the possible differences in the state of brain network between healthy subjects and those with depression as well as the type of measures taken to assess ketamine’s effect.</p><p>(2.3) A sentence was added (Discussion, last sentence of the 2nd paragraph) : Nevertheless, systematic studies are required to understand whether the reduced aversiveness to loss in our task might share the same mechanisms that underlie ketamine’s antidepressant action.</p><disp-quote content-type="editor-comment"><p>One question that comes to mind in terms of the selectivity observed is whether similar work has been done to examine the acute effects of any other drugs. If ketamine is unique in this regard, that would be quite interesting.</p></disp-quote><p>We think this is an interesting idea. However, comparing ketamine’s effect to that of other drugs is not the scope of the current study. We hope that we will be able to answer this question with future studies.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Oemisch and Seo set out to examine the effects of low-dose ketamine on reinforcement learning, with the idea that alterations in reinforcement learning and/or motivation might inform our understanding of what alterations co-occur with potential antidepressant effects. Macaques performed a reinforced/punished matching pennies task while under effects of saline or ketamine administration and the data were fit to a series of reinforcement learning models to determine which model described behavior under saline most closely and then what parameters of this best-fitting model were altered by ketamine. They found a mixed effect, with two out of three macaques primarily exhibiting an effect of ketamine on processing of losses and one out of three macaques exhibiting an effect of ketamine on processing of losses and perseveration. They found that these effects of ketamine appeared to be dissociable from the nystagmus effects of the ketamine.</p><p>The findings are novel and the data suggesting that ketamine is primarily having its effects on processing of losses (under the procedures used) are solid. However, it is unclear whether the connection between processing of losses and the antidepressant effects of ketamine is justified and the current findings may be more useful for those studying reinforcement learning than those studying depression and antidepressant effects. In addition, the co-occurrence of different behavioral procedures with different patterns of ketamine effects, with one macaque tested with different parameters than the other two exhibiting effects of ketamine that were best fit with a different model than the other two macaques, suggests that there may be difficulty in generalizing these findings to reinforcement learning more generally.</p><p>(1) First, the authors should be more explicit and careful in the connection they are trying to make about the link between loss processing and depression. The authors call their effect a &quot;robust antidepressant-like behavioral effect&quot; but there are no references to support this or discussion of how the altered loss processing would relate directly to the antidepressant effects.</p></disp-quote><p>We agree with the reviewer’s point on the way we made the connection between the study results and ketamine’s antidepressant action. This concern overlaps with the reviewer #1’s concern. Please refer to our response 2, 2-1, 2-2 and 2-3.</p><disp-quote content-type="editor-comment"><p>(2) It appears that the monkey P was given smaller rewards and punishers than the other two monkeys and this monkey had an effect of ketamine on perseveration that was not observed in the other two monkeys. Is this believed to be due to the different task, or was this animal given a different task because of some behavioral differences that preceded the experiment? The authors should also discuss what these differences may mean for the generality of their findings. For example, might there be some set of parameters where ketamine would only alter perseveration and not processing of losses?</p></disp-quote><p>Although the best-fitting ketamine model for monkey P includes an additional element – perseveration, we believe that monkey P’s baseline behavior and ketamine’s effect are not significantly different from the other two monkeys for the following reasons.</p><p>First, monkey P was the first animal that we tested ketamine’s effect, and therefore we aimed to match the other two monkeys’ baseline behavior similar to monkey P’s behavior in order to reduce variability in ketamine’s effect potentially attributable to the difference in baseline behavior before pharmacological manipulation. We had to adjust the payoff matrix for the subsequent animals (Y and B) because these monkeys were more sensitive to loss, and seldom chose “risky” target (yielding loss). In order to make the other two monkeys’ behavior similar to that of monkey P, we adjusted the asymmetry between the risky and the safe target in the way that loss (neutral) outcome occurred from the safe (risky) target as well. Eventually, this adjustment made the baseline behavior similar across all three monkeys. The goal of the study was to reliably measure the ketamine’s effect, and not to study individual differences that can naturally occur with the same task parameters. Therefore, we believe that the adjustment of payoff matrix helped to reliably detect ketamine’s effect starting from the common baseline behavior.</p><p>Second, the best-fitting model for monkey P (K-model 7) and that for the other two monkeys (K-model 4) make very similar predictions both qualitatively and quantitatively as are seen in the revised Figure 4. The parameters for outcome values estimated from these two models in monkey P are very similar as is seen in the revised Table 3. In addition, the difference in BIC between the model which includes only perseveration modulation (K-model 6) and the model incorporating outcome value modulation as well (K-model 7) is 441, whereas the difference in BIC between K-model 7 and the model that includes only outcome value modulation (K-model 4) is as small as 4. These BIC results indicate that the variability explained by ketamine’s modulation of outcome evaluation is remarkably larger that that explained by its modulation of perseveration in monkey P.</p><p>Therefore, we conclude that ketamine’s effect was not significantly different between monkey P and the other two monkeys. We clarified this in the revised manuscript by adding the following paragraph in the Result section:</p><p>“Unlike monkey Y and B, the best-fitting model for monkey P indicated that ketamine increased overall tendency to switch choice in addition to outcome-dependent modulation of outcome evaluation. However, BIC differed only slightly (dBIC = 3.99) between the best-fitting (K-model 7) and the second-best model (K-model 4) and the model predictions for choice behavior were very similar both qualitatively and quantitatively (Table 3, Figure 4). We conclude that the behavioral effects of ketamine were consistent across all three monkeys.”</p><disp-quote content-type="editor-comment"><p>(3) The authors should discuss whether the plasma ketamine levels they observed are similar to those seen with rapid antidepressant ketamine or are higher or lower.</p></disp-quote><p>We added a sentence in the first paragraph of the Result section as follows with a reference.</p><p>“Plasma concentration and its time course over 60 minutes were also comparable to those measured after 0.5mg/kg in human subjects (35).”</p><p>(35) Zarate CA, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, et al (2012): Relationship of ketamine’s plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry, 72: 331-338.</p><disp-quote content-type="editor-comment"><p>(4) For Figure 4 or S3, the authors should show the data fitted to model 7, which was the best for one of the animals.</p></disp-quote><p>We added the parameters and model predictions from both K-model 7 and K-model 4 for monkey P to help comparison between two models in Table 3, and Figure 4. Revised Table 3 and Figure 4 are as follows:</p><table-wrap id="sa3table1" position="float"><label>Author response table 1.</label><caption><title>Maximum likelihood parameter estimates of the best models for saline and ketamine sessions.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="top"/><th align="left" valign="bottom"><inline-formula><mml:math id="sa3m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="sa3m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>F</mml:mi><mml:mo>−</mml:mo><mml:mi>U</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="sa3m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>G</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="sa3m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></th><th align="left" valign="bottom"><inline-formula><mml:math id="sa3m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula></th></tr></thead><tbody><tr><td align="left" valign="bottom">P</td><td align="left" valign="top">Saline</td><td align="char" char="." valign="bottom">0.72</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">–0.57</td><td align="char" char="." valign="bottom">–1.3</td><td align="char" char="." valign="bottom">–2.31</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="top">Ketamine</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">0.40 (0.49)<break/></td><td align="char" char="." valign="bottom">0.11 (0.18)<break/></td><td align="char" char="." valign="bottom">–0.18 (-0.15)<break/></td></tr><tr><td align="left" valign="bottom">Y</td><td align="left" valign="top">Saline</td><td align="char" char="." valign="bottom">0.65</td><td align="char" char="." valign="bottom">0.20</td><td align="char" char="." valign="bottom">–0.54</td><td align="char" char="." valign="bottom">–1.91</td><td align="char" char="." valign="bottom">–3.15</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="top">Ketamine</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">0.31</td><td align="char" char="." valign="bottom">–0.18</td><td align="char" char="." valign="bottom">–0.95</td></tr><tr><td align="left" valign="bottom">B</td><td align="left" valign="top">Saline</td><td align="char" char="." valign="bottom">0.83</td><td align="char" char="." valign="bottom">0.19</td><td align="char" char="." valign="bottom">–1.07</td><td align="char" char="." valign="bottom">–2.26</td><td align="char" char="." valign="bottom">–4.12</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="top">Ketamine</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">0.18</td><td align="char" char="." valign="bottom">–0.25</td><td align="char" char="." valign="bottom">–1.01</td></tr></tbody></table></table-wrap><p>In all three animals, the model incorporating valence-dependent change in outcome evaluation best fit the choice data from ketamine sessions with (K-model 7 in the parenthesis, P) or without (K-model 4, P and Y/B) additional change in the tendency of choice perseveration (Figure 3, Table 3).</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><caption><title>ketamine-induced behavioral modulation simulated with differential forgetting model (for saline session) and best-fitting K-model (for ketamine session).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87529-sa3-fig1-v1.tif"/></fig></body></sub-article></article>